Marilyn Albert, Ph.D.
ADRC Co-Director of Administration Core

Email Address: malbert9@jhmi.edu

Marilyn Albert is currently Director of the Division of Cognitive Neuroscience in the Department of Neurology at Johns Hopkins University School of Medicine and Co-Director of the Johns Hopkins Alzheimer’s Disease Research Center. She moved to Johns Hopkins in 2003, after having been on the faculty of the Harvard Medical School for 22 years, where she directed the Gerontology Research Unit at Massachusetts General Hospital.

Dr. Albert received her PhD in Psychology from McGill University in 1969. She served as President of the International Neuropsychological Society in 1996 and was Director of the Harvard-Mahoney Neuroscience Institute from 1999 until her move to Johns Hopkins in 2003.

Dr. Albert is currently the Chair of the Medical & Scientific Advisory Committee of the national Alzheimer Association, which oversees the largest non-governmental grant program in AD research. In 2002, Dr. Albert and her husband, Dr. Guy McKhann, published a book for the general public about the aging brain entitled “Keep Your Brain Young”.

Her major research interests are in the area of cognitive change with age, disease-related changes of cognition (with a particular focus on Alzheimer's Disease) and the relationship of cognitive change to brain structure and function, as assessed through imaging. She has authored over 140 peer-reviewed publications.

Publications

Albert M, Jones K, Savage C, Berkman L, Seeman T, Blazer D, Rowe J. Predictors of cognitive change in older persons: MacArthur Studies of Successful Aging. Psychol & Aging. 1995; 10; 578-589.

Killiany R, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, Tanzi R, Jones K, Hyman B, Albert M. Use of structural magnetic resonance imaging to predict who will get Alzheimer’s disease. Ann Neurol. 2000; 47: 430-439.

Daly E, Komaroff A, Bloomingdale K, Wilson S, Albert M. Neuropsychological functioning in patients with Chronic Fatigue Syndrome, Multiple Sclerosis and Depression. Applied Neuropsychol. 2001; 8: 12-22.

Stern Y, Jacobs D, Goldman J, Gomez-Tortosa D, Hyman B, Liu Y, Troncoso J, Marder K, Tang M, Brandt J, Albert M. An investigation of clinical correlates of Lewy Bodies in autopsy-proven Alzheimer disease. Arch Neurol. 2001; 58: 460-465.

Albert M, Moss M, Tanzi R, Jones K. Preclinical prediction of AD using neuropsychological tests. J Interntl Neuropsychol Soc. 2001; 7: 631-639.

Sperling R, Bates J, Chua E, Cocchiarella A, Rentz B, Rosen B, Schacter D, Albert M. fMRI studies of associative encoding in young and elderly controls and mild AD patients. J Neurol, Neurosurg, Psychiat. 2003; 74: 44-50.

Copeland M, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, Albert M. Psychiatric symptomology and prodromal AD. Alzheimer’s Disease and Associated Disorders. 2003; 17: 1-8.

El Fakhri, Kijewski MF, Johnson KA, Syrkin G, Killiany R, Becker A, Albert M. MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer’s Disease. Arch Neurol. 2003; 60: 1066-1072.

Blacker D, Bertram L, Saunders A, Moscarillo T, Albert M, Perry R, Collins JS, Harrell LE, Go RCP, Mahoney A, Beaty T, Fallin MD, Avramopoulos D, Chase GA, Folstein MF, McInnis MG, Bassett SS, Doheny KJ, Pugh EW, Tanzi RE ( The NIMH Genetics Initiative Alzheimer’s Disease Study Group). Results of a high-resolution genome screen of 437 Alzheimer’s disease families. Hum Mol. Genet. 2003; 12: 23-32.